Ampio Pharmaceuticals Inc. Daily Stock Analysis

Daily Stock Analysis, AMPE, Ampio Pharmaceuticals Inc, priceseries

Ampio Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
0.46
Close
0.43
High
0.47
Low
0.43
Previous Close
0.47
Daily Price Gain
-0.04
YTD High
0.63
YTD High Date
Jan 4, 2022
YTD Low
0.39
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.19
YTD Gain
-30.61%
52 Week High
2.15
52 Week High Date
Mar 16, 2021
52 Week Low
0.39
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-1.04
52 Week Gain
-70.73%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 29. 2017
0.61
Oct 23. 2017
1.01
16 Trading Days
64.99%
Link
LONG
Nov 15. 2017
1.23
Nov 30. 2017
1.59
10 Trading Days
29.30%
Link
LONG
Dec 12. 2017
1.68
Jan 2. 2018
3.08
13 Trading Days
83.58%
Link
LONG
Mar 22. 2018
2.85
Apr 10. 2018
3.34
12 Trading Days
17.09%
Link
LONG
Jul 20. 2018
2.63
Aug 3. 2018
2.78
10 Trading Days
5.69%
Link
LONG
Jul 17. 2020
0.67
Aug 7. 2020
1.03
15 Trading Days
53.28%
Link
LONG
Nov 25. 2020
0.87
Dec 23. 2020
1.72
19 Trading Days
97.71%
Link
LONG
Feb 3. 2021
1.74
Feb 17. 2021
2.04
9 Trading Days
17.47%
Link
LONG
Aug 24. 2021
1.47
Sep 8. 2021
1.56
10 Trading Days
6.44%
Link
Company Information
Stock Symbol
AMPE
Exchange
NYSE MKT
Company URL
http://www.ampiopharma.com
Company Phone
720-437-6500
CEO
Michael Macaluso
Headquarters
Colorado
Business Address
373 INVERNESS PARKWAY, SUITE 200, ENGLEWOOD, CO 80112
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001411906
About

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Greenwood Village, CO.

Description

Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, which has completed Phase II clinical trials for diabetic macular edema. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading